AG sues Lilly for illegal marketing
Eli Lilly allegedly corrupted physicians, pharmacies and administrators at nursing homes and youth detention centers as part of an illegal marketing campaign to promote Zyprexa for unapproved off-label uses, including for the treatment of children.
The marketing campaign concealed risks associated with Zyprexa, including diabetes, cardiovascular problems, and significant weight gain.
In a lawsuit filed today, Blumenthal seeks to recover millions of taxpayer and consumer dollars improperly spent on Zyprexa as a result of its illegal marketing, and millions more spent for treatment of serious side effects from Zyprexa.
"The illegal marketing campaign exploited children and senior citizens - causing severe weight gain, diabetes and cardiovascular problems," Blumenthal said in a statement. "This scheme involved payments to public officials, bogus educational events and ghostwritten promotional articles summarizing suspect studies. The drug was marketed for anxiety, depression and Attention Deficit Disorder in children when it was never approved for any use in children and caused serious side effects."
WBJ Web Partners
Most Recent
Most Recent
0 Comments